Ishmael D. Aziati, PhD

Ishmael D. Aziati, PhD

Instructor of Medicine

Dr Aziati specializes in the use of integrated approaches to control and prevent emerging vector-borne and zoonotic viral diseases, with a special focus on pathogen surveillance and developing therapeutic interventions.

Shashwatee Bagchi, MD, MS, MSc

Shashwatee Bagchi, MD, MS, MSc

Associate Professor of Medicine

Dr. Bagchi specializes in clinical and translational research with a focus on cardiometabolic and vascular complications of infections.

Philip J. Budge, MD, PhD

Philip J. Budge, MD, PhD

Associate Professor of Medicine

Dr. Budge specializes in translational, public health-related research, with a special focus on filarial infections—insect-borne threadlike parasitic worms that cause lymphatic filariasis (elephantiasis), onchocerciasis (river blindness), and loiasis (African eye worm).

Michael S. Diamond, MD, PhD

Michael S. Diamond, MD, PhD

The Herbert S. Gasser Professor, Departments of Medicine, Molecular Microbiology, Pathology & Immunology

Michael Diamond, MD, PhD is the leader of a basic and translational research laboratory studying the interface between viral pathogenesis and host immunity. His laboratory focuses on emerging RNA viruses including flaviviruses, alphaviruses, and coronaviruses.

Peter U. Fischer, PhD

Peter U. Fischer, PhD

Professor of Medicine

Dr. Fischer specializes in basic and translational sciences to support the control and elimination of neglected tropical diseases, with a special focus on helminths.

Sumanth Gandra, MD, MPH

Sumanth Gandra, MD, MPH

Associate Professor of Medicine

Dr. Gandra specializes in clinical and public health research with a special focus on antibiotic use, antibiotic resistance surveillance and healthcare epidemiology in resource limited settings especially in India.

Languages: English,Telugu, Hindi

Elvin H.  Geng, MD, MPH

Elvin H. Geng, MD, MPH

Professor of Medicine

Using the lens of implementation science, Dr. Geng conducts research to advance the use of evidence-based interventions in the public health response to HIV and non-communicable diseases.

Juliet Iwelunmor, PhD

Juliet Iwelunmor, PhD

Professor of Medicine

A passionate advocate for health equity and sustainability, Dr. Iwelunmor is widely regarded for understanding how to make evidence-based interventions last, reshaping the focus on community engagement using participatory research, improving the dissemination of health information, while amplifying the voices of young people in health interventions.

Caline Mattar, MD

Caline Mattar, MD

Associate Professor of Medicine

Dr. Mattar’s interest is in healthcare epidemiology and global health, more specifically in infection prevention in resource limited settings. Additionally, her current work involves bloodtsream and endovascular infections.

 

Makedonka Mitreva, PhD

Makedonka Mitreva, PhD

The Robert E. and Louise F. Dunn Professor of Medical Sciences, Departments of Medicine and Genetics

Dr. Mitreva is an internationally acclaimed scientist who leads a basic and translational research program studying neglected tropical diseases, specifically helminth infections. Her enduring dedication to enhancing omics-driven discoveries and their clinical applications is paving the way for long-lasting improvements in global health.

Nongnooch Poowanawittayakom, MD

Nongnooch Poowanawittayakom, MD

Assistant Professor of Medicine

Dr. Poowanawittayakom interests are in bone and joint infection, infection prevention/control, hepatitis C, emerging infectious diseases, and global health.

William G. Powderly, MD

William G. Powderly, MD

J. William Campbell Professor of Medicine & Co-director, Infectious Diseases Division

Dr. Powderly has been actively involved in HIV-related clinical research for over thirty years with specific interests in opportunistic infections, metabolic complications and long-term outcomes of antiretroviral therapy.

Bruce A. Rosa, PhD

Bruce A. Rosa, PhD

Associate Professor of Medicine

Dr. Rosa’s experience in the statistical analysis of complex datasets (utilizing multiple types of evidence spanning treatments or species) has led to the identification differentially expressed genes, drug targets and pathways of interest for experimental verification.

Andrej Spec, MD, MSCI

Andrej Spec, MD, MSCI

Associate Professor of Medicine

Dr. Spec‘s research is in fungal infections, particularly in immunocompromised patients, including those with transplants. His research focuses on Cryptococcus, Histoplasma, Candida, Aspergillus and other invasive molds. Dr. Spec also runs the division’s clinic focusing on invasive fungal infections, where he takes care of both immunocompromised and immunocompetent patients with fungal infections, which he considers the best and most rewarding part of his job.

Gary J. Weil, MD

Gary J. Weil, MD

Gerald and Judith Medoff Professor of Infectious Diseases, Department of Medicine and Professor, Molecular Microbiology

Dr. Weil’s research group conducts research on filarial nematode parasites that cause important tropical diseases such as elephantiasis and river blindness. This includes basic research on parasite biology and translational research to develop improved diagnostic tests and treatments.